Medipan and GA Generic Assays

Startseite
Deutschland
Blankenfelde
Medipan and GA Generic Assays

With over 40 years of experience, we excel in Autoimmune Diagnostic Systems such as IFA, LINE/Dot Immunoassay, ELISA, and RIA.

Our expertise lies in immunological digital techniques for accurate autoimmune disease diagnoses.

24/08/2026

🔬 New insights into recurrent pregnancy loss and antiphospholipid antibodies Two recent studies published in Biomedicines provide new insights into the potential role of antiphospholipid antibodies (aPL) in women with recurrent pregnancy loss (RPL).

In the first study, an extended aPL profile was investigated in women with RPL. The researchers observed significant associations for anti-prothrombin, anti-annexin V and anti-β2-glycoprotein I (β2GPI) antibodies, highlighting the potential value of looking beyond established antibody profiles in research on unexplained RPL.

A subsequent study went one step further and explored a possible molecular link between aPL and endometrial receptivity. The findings point toward an association between anti-β2GPI antibodies and reduced endometrial HAND2 expression providing an interesting starting point for further research into immune-mediated mechanisms at the maternal–fetal interface.
We are pleased that in both studies; antiphospholipid antibodies were analyzed using the Anti-Phospholipid 10 Dot from GA Generic Assays.

These exploratory findings underline the importance of continued research into extended antiphospholipid antibody profiles and their potential biological relevance in reproductive medicine.

📖 Read the studies:

🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC13296882/

🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC13406172/

-Phospholipid10Dot

03/08/2026

How do the 2022 ACR/EULAR classification criteria improve the classification of ANCA-associated vasculitis? 🩸🔬

The 2022 ACR/EULAR classification criteria provide a more standardized and evidence-based framework for classifying ANCA-associated vasculitis ( ). By integrating clinical, laboratory, imaging, and histopathological findings, they support a more consistent distinction between granulomatosis with polyangiitis ( ), microscopic polyangiitis ( ), and eosinophilic granulomatosis with polyangiitis ( ).

As laboratory diagnostics play a central role in the classification process, understanding the significance of PR3-ANCA, MPO-ANCA, and other key biomarkers is essential.

Key topics covered:
• The laboratory markers behind the 2022 ACR/EULAR classification criteria
• The key differences between GPA, MPA, and EGPA
• Current EULAR recommendations for ANCA antibody testing
• The role of integrated IVD solutions in autoimmune diagnostics

📖 Read the full article: https://www.medipan.de/anca-associated-vasculitis-the-2022-classification-criteria-e-role-of-ivd-antibody-testing/?_thumbnail_id=109027

21/07/2026

Innovation für die Diagnostik von morgen - gefördert durch den EFRE 🔬

Die GA Generic Assays GmbH entwickelt im Rahmen eines durch den Europäischen Fonds für regionale Entwicklung (EFRE) geförderten Vorhabens innovative und qualitätsgesicherte Testkits für die Autoimmundiagnostik.
Im Mittelpunkt stehen die Entwicklung, Validierung und Herstellung standardisierter Assays, die optimal auf das von Medipan entwickelte KI-gestützte Fluoreszenzmikroskopiesystem abgestimmt sind.
Durch die Kombination aus hochsensitiven Testsystemen und intelligenter Automatisierung entstehen Lösungen für eine zuverlässige, reproduzierbare und zukunftsorientierte Diagnostik.

Mit der Förderung stärken wir unsere Innovationskraft, entwickeln neue diagnostische Standards und leisten einen Beitrag zur nachhaltigen biotechnologischen Wertschöpfung in Brandenburg.
Wir bedanken uns für die Unterstützung durch den Europäischen Fonds für regionale Entwicklung (EFRE). 🤝

21/07/2026

🚀 Wir freuen uns, ein neues Innovationsprojekt der Medipan GmbH vorzustellen, das durch den Europäischen Fonds für regionale Entwicklung (EFRE) gefördert wird.

Im Rahmen des Vorhabens entwickeln wir ein modulares, KI-gestütztes Fluoreszenzmikroskopiesystem für die automatisierte Autoimmundiagnostik. Durch die Kombination modernster optischer Technologien mit intelligenter Steuerungs- und Auswertesoftware schaffen wir eine Plattform für die standardisierte und digitale Analyse diagnostischer Proben.
💡 Unser Ziel ist es, die diagnostische Qualität, Objektivität und Effizienz nachhaltig zu verbessern, manuelle Auswertungsschritte zu reduzieren und neue Maßstäbe in der KI-basierten Bildanalyse zu setzen.

Wir bedanken uns für die Unterstützung durch den Europäischen Fonds für regionale Entwicklung und freuen uns darauf, gemeinsam die Zukunft der Labordiagnostik mitzugestalten.

29/06/2026

June 29 is World Scleroderma Day 🌍

Scleroderma, also known as systemic sclerosis, is a rare autoimmune disease that can have a profound impact on daily life. It is characterized by the hardening and tightening of the skin and connective tissue and may also affect internal organs such as the lungs, heart, lungs, kidneys, and digestive system.

Because symptoms can vary significantly from patient to patient, diagnosis is often complex and may take time. Early recognition is essential, however, to help prevent irreversible organ damage and improve long-term outcomes.

A comprehensive diagnostic approach typically combines several methods, including:
• Clinical evaluation of skin changes and symptoms such as Raynaud’s phenomenon
• Autoantibody testing (e.g. ANA, Scl-70, CENP-A/CENP-B, RNA Polymerase III, PM/Scl)
• Indirect immunofluorescence (IFA) on HEp-2 cells as a sensitive screening tool
• Immunoblot and other assays to support disease differentiation
• Functional and imaging-based assessments to evaluate potential organ involvement

Each method contributes a different piece of the diagnostic puzzle - together they enable a more complete clinical picture 🧩

To learn more about scleroderma and its diagnostic challenges, read our article: https://www.medipan.de/understanding-scleroderma-and-its-diagnostic-tests/

Hashtag

17/06/2026

Scientific congresses do more than showcase new research: they often provide a valuable glimpse into the trends that will shape the future of diagnostics and clinical decision-making.

At 15th International Congress on 2026, discussions around AI-supported ANA interpretation, ongoing standardization initiatives, novel biomarker discovery, and disease-specific advances clearly demonstrated how autoimmune diagnostics is steadily evolving toward greater precision, reproducibility, and clinical relevance. Across sessions, a common theme emerged: the integration of digital tools, improved assay harmonization, and deeper biological insights is increasingly bridging the gap between laboratory data and patient care.💎

To capture these developments, our team has summarized the key scientific takeaways and their potential implications for laboratories, clinicians, and patients in a new article.

📖 Read our congress highlights here: https://www.medipan.de/autoimmunity-congress-2026-key-insights-in-autoimmune-diagnostics-ai-and-standardization/

Which of the innovations presented at Autoimmunity 2026 do you believe will have the greatest impact on autoimmune diagnostics in the coming years?

11/06/2026

Following a successful participation at WHX Lagos 2026, we would like to thank our distribution partner First KBZ Nigeria Limited for representing Medipan & GA Generic Assays in the West African market.

Visitors to the booth had the opportunity to learn more about our ®NEO and .0 systems and their applications in modern laboratory diagnostics. The positive feedback and numerous valuable conversations made the event a great success. 👏

.0

04/06/2026

🔬 New International Consensus on Ro Autoantibody Nomenclature
A new international consensus has proposed updated and standardized terminology for the historically confusing “SSA/Ro” autoantibodies.
After a global expert consensus process, the use of the term SSA (Sjögren syndrome antigen A) is no longer recommended. Instead, the following nomenclature should be used:

Ro60 ➡️anti-TROVE2
Ro52 ➡️anti-TRIM21

Although these autoantibodies are often reported together, they target distinct antigens with different biological functions and clinical associations.

📌 anti-TROVE2 / Ro60
• Primarily associated with Systemic Lupus Erythematosus (SLE) and Sjögren’s Disease (SjD)
• Involved in RNA quality control
• Localized in both nucleus and cytoplasm

📌 anti-TRIM21 / Ro52
• Found across a broader spectrum of autoimmune diseases, including SLE, Sjögren’s Disease, autoimmune hepatitis, primary biliary cholangitis, inflammatory myopathies, systemic sclerosis, and interstitial lung disease
• Plays a key role in innate immunity, interferon regulation, and apoptosis
• Detected in up to 60–75% of patients with Sjögren’s Disease

The adoption of this updated nomenclature represents an important step toward greater scientific clarity, improved diagnostic precision, and harmonized reporting across laboratories, clinical practice, and research.

📖 Read the full study here: https://www.sciencedirect.com/science/article/pii/S0003496726002281

18/05/2026

One day after the 15th International Congress on Autoimmunity in Prague, we would like to share a few final impressions from the past days. 💫

For us, the congress was not only about diagnostics and scientific exchange, but also about reconnecting with long-standing partners, meeting new people from the autoimmune community, and seeing many familiar faces again.

We truly appreciated the many conversations at our booth, from discussions about current challenges in autoimmune diagnostics to exchanging experiences and ideas for the future 🧬

A special thank you to everyone who stopped by and took the time to connect with us during the congress, and of course to our team on site for their great support and commitment throughout the event 👏

We are already looking forward to the next Autoimmunity Congress!

14/04/2026

We are pleased to announce that Medipan GmbH & GA Generic Assays GmbH will once again be participating in the 15th this year – this time in the beautiful city of Prague. 🇨🇿

The Autoimmunity Congress is one of the leading international platforms for exchanging knowledge, presenting new research, and connecting with experts in the field of autoimmune diagnostics and therapy.

We are very much looking forward to insightful discussions, meeting colleagues and partners from around the world, and sharing our latest developments in autoimmune diagnostics. 🧬

📍 Visit us at Booth 17

We look forward to seeing you there!

For more information or to schedule a meeting with our staff, please visit our website:
https://www.medipan.de/2026-05-medipan-ga-generic-assays-at-the-15th-autoimmunity-congress

Adresse

Ludwig-Erhard-Ring 3
Blankenfelde
15827

Webseite

https://www.medipan.de/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Medipan and GA Generic Assays erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.